https://clgtrial.com/wp-content/uploads/2019/12/Carter-Law-Logo-Horizontal-.png 0 0 Heather Davis https://clgtrial.com/wp-content/uploads/2019/12/Carter-Law-Logo-Horizontal-.png Heather Davis2021-12-03 05:00:002021-12-03 05:00:00Gilead Issues A Voluntary Nationwide Recall of Two Lots of Veklury® (Remdesivir) Due to Presence of Glass Particulates
Gilead Issues A Voluntary Nationwide Recall of Two Lots of Veklury® (Remdesivir) Due to Presence of Glass Particulates
Foster City, CA, Gilead Sciences Inc. (Nasdaq: GILD) today announced it is voluntarily recalling two lots of Veklury® (remdesivir 100 mg for injection) to the user level. Gilead Sciences Inc. received a customer complaint, confirmed by the firm’s investigation, of the presence of glass particulates.
Source: Food and Drugs Administration--Recalls/Safety Alerts